IP Library Granted Patent US 11,007,162
Granted Patent B2
US 11,007,162 · App. 16/176,349 · Granted May 18, 2021

Methods of reducing small, dense LDL particles

Inventors: David Karpf (Mountain View, CA); Ronald M. Krauss (Berkeley, CA); Yun-Jung Choi (Fremont, CA); Xueyan Wang (Foster City, CA); Francine M. Gregoire (Newton, MA)
Assignee: CymaBay Therapeutics, Inc.
A61K31/192A61K31/09A61K31/4015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,007,162
App. No.
16/176,349
Granted
May 18, 2021
Kind
B2
Abstract

The present invention provides methods for increasing LDL particle size.

Claims (14)

1. A method of changing the LDL particle size pattern in a human having LDL particle size pattern I or B, from pattern I to pattern A, or from pattern B to pattern I or A, comprising:

(i) the identification of the human as having LDL particle size pattern I or B; and

(ii) the administration to the human of a therapeutically effective amount of a compound of the formula

or a salt thereof;

thereby changing the LDL particle size pattern of the human from pattern I to pattern A, or from pattern B to pattern I or A.

2. The method of claim 1 , where the human is identified as having an LDL particle size pattern B prior to administration of the compound.

3. The method of claim 2 , where the human is identified as having an LDL particle size pattern I after administration of the compound.

4. The method of claim 1 , where the human has diabetes.

5. The method of claim 1 , where the human is insulin resistant.

6. The method of claim 1 , where the human has atherosclerosis.

7. The method of claim 1 , where the human has metabolic syndrome.

8. The method of claim 1 , where the human has dyslipidemia.

9. The method of claim 1 , further comprising administration to the human of a statin.

10. The method of claim 9 , where the statin is atorvastatin.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2024
From: ABW CYCLOPS SPV LP
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 069833/0155 →
NUNC PRO TUNC ASSIGNMENT Recorded May 14, 2020
From: CHILDREN'S HOSPITAL AND RESEARCH CENTER AT OAKLAND
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 052663/0491 →